Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1348770.RA3vylD05wxCprxnr79RnhOchd58AoiCQy37tXnzlRz5k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1348770.RA3vylD05wxCprxnr79RnhOchd58AoiCQy37tXnzlRz5k130_assertion type Assertion NP1348770.RA3vylD05wxCprxnr79RnhOchd58AoiCQy37tXnzlRz5k130_head.
- NP1348770.RA3vylD05wxCprxnr79RnhOchd58AoiCQy37tXnzlRz5k130_assertion description "[The loss of sst2 expression could represent a growth advantage in these tumors and provide an explanation for the lack of therapeutic effect of somatostatin analogues in such adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1348770.RA3vylD05wxCprxnr79RnhOchd58AoiCQy37tXnzlRz5k130_provenance.
- NP1348770.RA3vylD05wxCprxnr79RnhOchd58AoiCQy37tXnzlRz5k130_assertion evidence source_evidence_literature NP1348770.RA3vylD05wxCprxnr79RnhOchd58AoiCQy37tXnzlRz5k130_provenance.
- NP1348770.RA3vylD05wxCprxnr79RnhOchd58AoiCQy37tXnzlRz5k130_assertion SIO_000772 8620499 NP1348770.RA3vylD05wxCprxnr79RnhOchd58AoiCQy37tXnzlRz5k130_provenance.
- NP1348770.RA3vylD05wxCprxnr79RnhOchd58AoiCQy37tXnzlRz5k130_assertion wasDerivedFrom befree-2016 NP1348770.RA3vylD05wxCprxnr79RnhOchd58AoiCQy37tXnzlRz5k130_provenance.
- NP1348770.RA3vylD05wxCprxnr79RnhOchd58AoiCQy37tXnzlRz5k130_assertion wasGeneratedBy ECO_0000203 NP1348770.RA3vylD05wxCprxnr79RnhOchd58AoiCQy37tXnzlRz5k130_provenance.